Korea Surgical Quality Improvement Program
Overview
The member of National Evidence-based Healthcare Collaborating Agency and the planning committee of Korean Association of hepato-biliary pancreatic Surgery established the protocol of Korean Surgical Quality Improvement Program (KSQIP) with verifying variables of American College of Surgeons – National Surgical Quality Improvement Program (ACS-NSQIP and National Clinical Database (NCD) of Japan; demographics, preoperative information, laboratory values, operation finding, general occurrences, postoperative occurrences, and follow-up data to develop post cholecystectomy complication risk model. The 50 surgeons from 20 hospitals have decided to participated in the primary prospective study to apply KSQIP to cholecystectomy. The investigators developed web-based database system (http://www.ksqip.org/gb) and surgical clinical reviewer of each hospital will fill out the case report form. Finally, the investigators will provide a risk-adjusted surgical risk calculator and feedback system for reducing complication.
Full Title of Study: “Development of Cholecystectomy Complication Predictive Model for Developing the Surgical Quality Improvement Program”
Study Type
- Study Type: Observational [Patient Registry]
- Study Design
- Time Perspective: Prospective
- Study Primary Completion Date: June 2017
Interventions
- Procedure: cholecystectomy
- Laparoscopic surgery Reverse Trendelenburg position Skin incision and trocar insertion CO2 gas insufflation Intra-abdominal inspection and gallbladder exposure Gallbladder traction Calot triangle exposure Cystic artery and cystic duct isolation Gallbladder bed dissection Bleeding control Gallbladder extraction Trocar removal and wound closure Open surgery Supine position Skin incision Intra-abdominal inspection and gallbladder exposure 5. Gallbladder traction 6. Calot triangle exposure 7. Cystic artery and cystic duct isolation 8. Gallbladder bed dissection 9. Gallbladder extraction 10. Bleeding control 11. Wound closure
Clinical Trial Outcome Measures
Primary Measures
- Composite of bile leakage and iatrogenic duct injury
- Time Frame: 1 month
Participating in This Clinical Trial
Inclusion Criteria
- Patient who underwent cholecystectomy with cholecystitis or gallbladder polyp or cholelithiasis Exclusion Criteria:
- Under 18 age – Who underwent other abdominal surgery simultaneously – Gallbladder Cancer, cholangiocarcinoma – Who did not agree with participation
Gender Eligibility: All
Minimum Age: 18 Years
Maximum Age: N/A
Are Healthy Volunteers Accepted: No
Investigator Details
- Lead Sponsor
- National Evidence-Based Healthcare Collaborating Agency
- Provider of Information About this Clinical Study
- Sponsor
Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.